Samsung has received U.S. Food and Drug Administration (FDA) 510(k) clearance for version 3.02 of its S-Vue digital radiography (DR) image postprocessing engine, which is designed to significantly lower radiation dose for pediatric patients.
After comparing S-Vue 3.02 with the firm's previous postprocessing engine on phantoms and in clinical studies, Samsung said that DR systems using S-Vue were able to lower dose by up to 45% for pediatric abdomen exams, by 15.5% for pediatric chest studies, and by up to 27% for pediatric skull exams.
S-Vue 3.02 is available on Samsung's GC85A and GM85 DR systems.